| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23K | — | +189.4% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $70 | — | +0.0% |
| Operating Income | -$182 | — | -134.0% |
| Net Income | $32K | — | +5885.3% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $31K | — | — |
| Total Assets | $499.4M | — | — |
| Total Liabilities | $2K | — | — |
| Stockholders' Equity | $499.4M | -0.0% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$528 | — | — |
| Investing Cash Flow | -$499.4M | — | — |
| Financing Cash Flow | $40 | — | — |